A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study.

Abstract

5501Background: GOG-0213 is an international, open-label, randomized phase 3 trial in women with PSOC with two objectives: 1) to study the addition of B to paclitaxel/carboplatin concurrently and a...